Jhs Svendgaard Laboratories Profile
Key Indicators
- Authorised Capital ₹ 85.00 Cr
- Paid Up Capital ₹ 64.90 Cr
- Company Age 20 Year, 3 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 6.30 M
- Satisfied Charges ₹ 199.74 Cr
- Revenue Growth 7.87%
- Profit Growth -520.10%
- Ebitda -4607.16%
- Net Worth -7.88%
- Total Assets 1.10%
About Jhs Svendgaard Laboratories
Jhs Svendgaard Laboratories Limited (JSLL) is a leading Public Limited Indian Non-Government Company incorporated in India on 08 October 2004 and has a history of 20 years and three months. Its registered office is in Himachal Pradesh, Himachal Pradesh, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 532771 and on the National Stock Exchange(NSE) under JHS.
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 85.00 Cr and a paid-up capital of Rs 64.90 Cr.
The company currently has active open charges totaling ₹6.30 M. The company has closed loans amounting to ₹199.74 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Jhs Svendgaard Laboratories Limited India are Paramvir Singh as the Chief Executive Officer (CEO), Deepesh Sharma as serving as the Chief Financial Officer (CFO), Ashish Goel as serving as the Chief Financial Officer (CFO), and One other members. Rajagopal Venkateish, Mukul Pathak, Nikhil Nanda, and Three other members serve as directors at the Company.
Company Details
- Location
Himachal Pradesh, Himachal Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
Industry
What products or services does Jhs Svendgaard Laboratories Limited offer?
Jhs Svendgaard Laboratories Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Brain & Nervous System Drugs, Psychotherapeutic Agents, Antidepressant & Anti Anxiety Medicines, Pain Relief Drugs & Pharmaceuticals, Anti Inflammatory Drugs, Common Disease Medicines, Injectable Products, Sexual Wellness Products.
Who are the key members and board of directors at Jhs Svendgaard Laboratories?
Executive Team (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nikhil Nanda  | Managing Director | 08-Oct-2004 | Current |
| Paramvir Singh | CEO(Kmp) | 30-May-2014 | Current |
| Deepesh Sharma | CFO(Kmp) | 30-May-2023 | Current |
| Ashish Goel | CFO(Kmp) | 14-Aug-2018 | Current |
| Komal Jha | Company Secretary | 10-Nov-2022 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rohina Sangtani | Director | 21-Nov-2017 | Current |
| Kapil Minocha | Director | 23-Jun-2020 | Current |
| Rajagopal Venkateish | Director | 23-Jun-2020 | Current |
| Mukul Pathak | Director | 01-Jan-2006 | Current |
| Vinay Mittal | Director | 27-May-2022 | Current |
Financial Performance of Jhs Svendgaard Laboratories.
Jhs Svendgaard Laboratories Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.87% increase. The company also saw a substantial fall in profitability, with a 520.1% decrease in profit. The company's net worth dipped by a decrease of 7.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jhs Svendgaard Laboratories?
In 2023, Jhs Svendgaard Laboratories had a promoter holding of 42.23% and a public holding of 57.77%. The company had 4 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jhs Svendgaard Retail Ventures LimitedNikhil Nanda is a mutual person
- Number One Enterprises Private Limited
Nikhil Nanda is a mutual person
Lex Sportel Vision Private LimitedRajagopal Venkateish is a mutual person
- Lex Entertainment And Media Private Limited
Rajagopal Venkateish is a mutual person
- Dnr Industries Private Limited
Mukul Pathak is a mutual person
- Maya Brands Llp
Nikhil Nanda is a mutual person
Charges (Loans)
₹0.63 Cr
₹199.74 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.33 Cr
- Commissioner Of Industries Himachal Pradesh Member Secretary Single Window Clearance Agency : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Oct 2021 | Hdfc Bank Limited | ₹2.30 M | Open |
| 15 Feb 2019 | Hdfc Bank Limited | ₹1.00 M | Open |
| 26 Dec 2007 | Commissioner Of Industries Himachal Pradesh Member Secretary Single Window Clearance Agency | ₹3.00 M | Open |
| 16 May 2018 | Kotak Mahindra Bank Limited | ₹6.25 Cr | Satisfied |
| 22 Dec 2017 | Hdfc Bank Limited | ₹3.00 M | Satisfied |
How Many Employees Work at Jhs Svendgaard Laboratories?
Jhs Svendgaard Laboratories has a workforce of 240 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jhs Svendgaard Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jhs Svendgaard Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
